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INTRODUCTION
Recent evidence has demonstrated the beneficial effect of ex-
ercise based cardiac rehabilitation (CR) in improving clinical 
outcomes and secondary prevention for acute myocardial in-
farction.1-3 Thus, current practical guidelines recommend re-
ferral to CR with exercise training for patients with myocardial 
infarction or chronic stable angina. However, very little re-
search has been conducted to clarify the impact of exercise 
training on clinical outcomes in patients with ST-elevation 
myocardial infarction (STEMI) undergoing primary percuta-
neous coronary intervention (PCI) with drug-eluting stents 
(DESs) implantation on the infarct-related artery. Moreover, 
several studies have reported that only 22–30% of patients 
with myocardial infarction participate in CR programs.4-6 
Since guidelines recommend that patient counseling to maxi-
mize adherence to evidence-based post-STEMI treatment 
should begin during the early phase of hospitalization, occur 
intensively at discharge, and continue at follow-up visits, un-
derutilization of exercise-based CR, especially in patients with 
myocardial infarction, may deprive an important therapy in 
these high-risk patients. Thus, it is important to determine 
who can benefit from CR with ET in patients with myocardial 
infarction. 
In the present study, we aimed 1) to evaluate whether exer-
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cise-based CR improves major adverse cardiovascular events 
(MACEs) in patients with STEMI undergoing primary PCI in 
the current DES era and 2) to find subsets of patients that 
would benefit most from exercise-based CR.
MATERIALS AND METHODS 
A total of 265 patients who underwent primary PCI for STEMI 
between 2009 and 2014 were screened. All patients were en-
couraged to participate in CR with an exercise program unless 
they had third degree atrioventricular block, severe aortic ste-
nosis, systolic blood pressure above 200 mm Hg at rest, dia-
stolic blood pressure above 110 mm Hg at rest, pericarditis, 
uncontrolled tachycardia, exercise induced malignant ven-
tricular arrhythmia, acute systemic illness, skeletal vascular 
disease, or acute metabolic disorders. The patients who were 
unwilling to provide informed consent to the exercise training 
program were also excluded. Finally, a total of 254 STEMI pa-
tients were enrolled in this study, and 76 of 254 STEMI pa-
tients (30%) participated in the exercise-based CR program. 
Of 178 nonparticipants, 120 patients refused to participate in 
the CR program, and 58 patients did not complete the planned 
CR program. The Institutional Review Board of Sanggye Paik 
Hospital approved this study. The requirement for informed 
consent was waived because of the retrospective nature of the 
study (IRB number: 2019-01-003-001, IRB institution: Sanggye 
Paik hospital, Inje University).
Participation in the CR program was defined as commence-
ment of a CR session starting within 4 weeks of the index PCI 
and completion of phase 2 supervised exercise in the hospital 
for a period of 6–8 weeks and maintenance of community-
based self-managed exercise over 9 months.7 Cardiorespirato-
ry capacity was measured twice by a symptom-limited tread-
mill exercise test under the protocol of modified Bruce before 
the commencement and at the end of the phase 2 supervised 
exercise training. Maximal oxygen uptake (VO2max) was de-
fined as the highest valuce or the plaeteau of directly mea-
sured oxygen consumption using a respiratory gas analyzer 
(QMC, Quinton Intrument CO., Boston, MA, USA). The exer-
cise test was supervised by experienced physicians and ECG 
monitoring was conducted throughout the test. The exercise 
program included a 10-minute warm-up, a 40-minute aerobic 
exercise on a treadmill, and a 10-minute cool-down phase. 
Exercise intensity in the first stage was gradually increased 
from 50% to 80% of VO2max determined by the exercise test. 
After the 6 weeks of supervised exercise, community-based 
and self-managed exercise was performed according to the 
reassessed cardiorespiratory capacity. Patients were required 
to exercise at a local fitness center and maintain aerobic exer-
cise on a treadmill in a same manner. Every exercise training 
session should be composed of 1 hour, and patients were re-
quired to exercise three times a week. Adherence to exercise 
was monitored every month at an outpatient clinic.7
MACE was defined as the composite of death, myocardial 
infarction, and revascularization. Clinical events were defined 
according to the Academic Research Consortium and an ex-
pert consensus document that defined the third universal 
definition for myocardial infarction.8,9 All deaths were consid-
ered cardiac related unless an unequivocal non-cardiac cause 
could be established.8 During follow up, myocardial infarction 
was defined by the following parameters: the presence of 
clinical symptoms, ECG changes, or abnormal imaging find-
ings indicative of myocardial infarction and an increase in 
creatine kinase myocardial band fraction above the upper 
normal limits or an increase in troponin-T/troponin-I above 
the 99th percentile of the upper normal limit. Any revascular-
ization was defined as a repeat PCI or bypass surgery.9
Statistical analyses were performed using IBM SPSS, ver-
sion 19.0 (IBM Corp., Armonk, NY, USA). Categorical vari-
ables are reported as numbers and percentages. Continuous 
variables are reported as a mean and SD. Cumulative MACEs 
at 1 year and 3 year were calculated using Kaplan-Meier esti-
mates and compared using the log-rank test. Although pa-
tients could experience more than one MACE component, 
each patient was assessed until the occurrence of the first 
event during analysis. Also, factors associated with MACE 
were determined by performing a univariable analysis using 
Cox proportional hazards regression with all variables listed 
in Tables 1 and 2. All variables achieving a p value <0.10 in 
univariate analysis were entered using the enter method into 
a multivariate analysis model. Subgroup analyses were per-
formed according to clinical and angiographic subgroups. All 
tests were two-sided, and a p value <0.05 was considered sta-
tistically significant. 
RESULTS
Of 254 STEMI patients who were eligible for the exercise pro-
gram, 76 patients (30%) participated in CR with an exercise 
program the during study period (CR+ group). Nonpartici-
pants to CR (178 of 254 STEMI patients, CR- group) comprised 
those who were under standard medical care for myocardial 
infarction, including medication, abstinence from smoking, 
and diet modification during study period. Baseline clinical 
characteristics according to the CR group are presented in Table 
1. There were no significant differences in baseline character-
istics, including age, sex, body mass index, diabetes, hyper-
tension, and left ventricular ejection fraction. Angiographic 
characteristics are presented in Table 2. There were no signifi-
cant differences in initial thrombolysis in myocardial infarc-
tion (TIMI) grade, severity of coronary artery disease, location 
of infarct-related artery, and lesion morphology. Among 254 
patients, 238 (94%) patients received second-generation DESs.
Clinical outcomes are presented in Table 3. During a medi-
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an follow up of 943 days (interquartile range: 514–1096 days), 
MACEs occurred in 37 patients. At 1 year, the MACEs did not 
differ between groups [7.0% vs. 9.1%, hazard ratio (HR)=0.58, 
95% confidence interval (CI)=0.19–1.75, p=0.326]. At 3 years, 
although not statistically significant, the CR+ group had fewer 
MACEs than the CR- group, (9.9% vs. 18.3%, HR=0.54, 95% 
CI=0.23–1.24, p=0.138) (Fig. 1). As for clinical outcomes, all-
cause death at 3 years was significantly lower in the CR+ 
group than in the CR- group (0% vs. 5.4%, p=0.033). Cardiac 
death, myocardial infarction, and any revascularization were 
not different between groups. Univariable and multivariable 
Table 1. Baseline Characteristics
CR+ group
n=76
CR- group
n=178
p value
Age (yr) 59±11 60±14 0.846
Male 63 (83) 146 (82) 0.868
BMI (kg/m2) 24.5±3.8 24.1±2.9 0.396
Hypertension 33 (43) 86 (48) 0.474
Diabetes 13 (17) 41 (23) 0.290
Dyslipidemia 8 (11) 22 (12) 0.678
Smoking 0.084
Never 28 (37) 52 (29)
Ex-smoker 18 (24) 29 (16)
Current smoker 30 (41) 97 (55)
Prior myocardial infarction 2 (3) 5 (3) 0.937
Prior percutaneous coronary intervention 3 (4) 12 (7) 0.387
Previous cerebrovascular event 4 (5) 12 (7) 0.657
Left ventricular ejection fraction (%) 54±11 51±11 0.087
Medication at discharge
Aspirin 76 (100) 174 (98) 0.188
Clopidogrel 71 (93) 156 (88) 0.171
Ticagrelor 5 (7) 18 (10) 0.369
ACE inhibitor or ARB 39 (51) 95 (53) 0.764
Beta-blocker 61 (80) 132 (74) 0.297
Statin 75 (99) 173 (97) 0.473
ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; 
BMI, body mass index; CR, cardiac rehabilitation.
Numbers are presented as a mean±SD or number (percentage).
Table 2. Angiographic Characteristics
CR+ group
n=76
CR- group
n=178
p value
Preprocedural TIMI grade 0.440
0 39 (51) 89 (50)
1 11 (15) 22 (12)
2 6 (8) 27 (15)
3 20 (26) 40 (22)
Postprocedural TIMI grade 0.667
1 0 (0) 1 (1)
2 7 (9) 21 (12)
3 69 (91) 156 (88)
Severity of coronary artery disease 0.066
1 45 (59) 80 (45)
2 23 (30) 62 (35)
3 8 (11) 36 (20)
Location of infarct-related artery 0.218
Left anterior descending 42 (55) 92 (52)
Left circumflex 3 (4) 19 (11)
Right coronary artery 31 (41) 67 (38)
Lesion morphology 0.202
A 7 (8) 14 (8)
B1 12 (16) 16 (9)
B2 28 (37) 57 (32)
C 29 (38) 91 (51)
Type of stent 0.599
No use of stent 0 (0) 3 (2)
Bare-metal stent 2 (3) 4 (2)
First-generation DES 3 (4) 4 (2)
Second-generation DES 71 (93) 167 (94)
CR, cardiac rehabilitation; DES, drug-eluting stent; TIMI, thrombolysis in 
myocardial infarction.
Numbers are a presented as number (percentage). 
Table 3. Clinical Outcomes
CR+ group
n=76
CR- group
n=178
HR (95% CI)
Log-rank
p value
At 1 year
MACE 4 (7.0) 15 (9.1) 0.58 (0.19–1.75) 0.326
All-cause of death 0 (0) 7 (4.2) - 0.078
Cardiac death 0 (0) 0 (0) - 0.999
Myocardial infarction 0 (0) 2 (1.2) - 0.339
Revascularization 4 (5.6) 6 (3.8) 1.43 (0.41–5.08) 0.575
At 3 year
MACE 7 (9.9) 27 (18.3) 0.54 (0.23–1.24) 0.138
All-cause of death 0 (0) 9 (5.4) - 0.033
Cardiac death 0 (0) 1 (1.0) - 0.440
Myocardial infarction 0 (0) 3 (2.1) - 0.227
Revascularization 7 (9.9) 19 (12.6) 0.88 (0.38–2.02) 0.755
CR, cardiac rehabilitation; HR, hazard ratio; CI, confidence interval; MACE, major adverse cardiovascular event.
MACE was defined as a composite of death, myocardial infarction, and revascularization. Event rates were calculated by Kaplan-Meier curves. 
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analyses for MACE are also presented in Supplementary Table 
1 (only online). 
In subgroup analysis to identify patients who would benefit 
from CR, we found a significant interaction between the CR 
group and preprocedural TIMI flow (Fig. 2). The CR+ group 
had significantly fewer MACEs in the subgroup of patients 
with lower TIMI flow (TIMI flow ≤1, n=161) than in the sub-
group of patients with higher TIMI flow (TIMI flow ≥2, n=93) 
(p-value for interaction=0.011). Also, among patients with low 
TIMI flow (TIMI flow ≤1), the CR+ group had significantly 
fewer MACEs than the CR- group (p=0.005) (Fig. 3). However, 
among patients with higher TIMI flow (TIMI flow ≥2), MACEs 
were not different between groups (p=0.247) (Fig. 3). There 
were no significant differences in baseline characteristics ac-
cording to preprocedural TIMI flow (Supplementary Table 2, 
only online).
DISCUSSION
The main findings of the present study are that, although the 
CR+ group only exhibited a lower tendency for MACEs than 
the CR- group after 3 years, there was a significant interaction 
in subgroup analysis according to the CR group and prepro-
cedural TIMI flow. The CR+ group had significantly lower 
MACE than the CR- group, particularly in patients with low 
Fig. 1. Kaplan-Meier survival curves of MACEs according to CR. CI, confi-
dence interval; CR, cardiac rehabilitation; HR, hazard ratio; MACE, major 
adverse cardiovascular event; PCI, percutaneous coronary intervention.
30
20
10
0
0                                     1                                     2                                    3
Years after primary PCI
HR=0.54 (95% CI=0.23–1.24)
Log-rank p=0.138
CR- group
CR+ group
M
AC
E 
ra
te
 (%
)
Fig. 2. Subgroup analysis of major adverse cardiovascular events. CI, confidence interval; CR, cardiac rehabilitation; HR, hazard ratio; LAD, left anterior 
descending; LCx, left circumflex; RCA, right coronary artery; TIMI, thrombolysis in myocardial infarction.
Subgroup
CR (+) CR (-)
HR
(95% CI) p value
No. of 
patients
(n/N)
Event
 rate
(%)
No. of 
patients
(n/N)
Event 
rate
(%)
All patients 7/76 9.9 27/178 18.3 0.58 (0.23–1.24) 0.138
Age (yr)
≤65 6/57 10.9 17/111 17.8 0.63 (0.25–1.59) 0.320
>65 1/19 6.2 1-/67 19.0 0.32 (0.04–2.47) 0.245
Sex
Male 7/63 11.9 24/146 20.2 0.59 (0.26–1.38) 0.221
Female 0/13 0 3/32 10.1 - 0.264
Hypertension
Yes 2/33 6.7 14/86 19.8 0.32 (0.07–1.41) 0.111
No 5/43 12.3 13/92 16.9 0.75 (0.27–2.11) 0.585
Diabetes melitus
Yes 2/13 16.7 8/41 22.2 0.71 (0.15–3.34) 0.661
No 5/63 8.5 19/137 17.8 0.51 (0.19–1.36) 0.168
Left ventricular ejection fraction
≤40% 0/9 0 5/31 19.3 - 0.209
>40% 7/67 11.0 22/147 15.9 0.62 (0.27–1.46) 0.269
No. of diseased vessels
One or two 6/68 9.4 20/142 17.3 0.55 (0.22–1.38) 0.193
Three 1/8 14.3 7/36 22.6 0.67 (0.08–5.46) 0.706
Coronary arteries
LAD 5/42 12.1 12/92 15.2 0.79 (0.28–2.25) 0.663
LCx or RCA 2/34 6.8 15/86 21.5 0.31 (0.07–1.35) 0.098
Initial TIMI grade
0 ro 1 1/50 2.1 19/111 20.0 0.24 (0.13–0.74) 0.005
2 or 3 6/26 25.6 8/67 15.3 1.85 (0.64–5.34) 0.247
p value
for 
interaction
0.536
-
0.359
0.736
-
0.92
0.319
0.011
Favors
CR (+)
Favors
CR (-)
0.1       0.2            0.5       1.0        2.0            5.0       10.0
HR (95% CI)
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TIMI flow, during primary PCI, whereas MACE was not differ-
ent between groups among patients with higher TIMI flow, 
suggesting that CR with exercise training would be most clini-
cally beneficial to patients with low preprocedural TIMI flow 
during primary PCI for STEMI in the current DES era.
Much evidence has demonstrated the beneficial effect of 
CR including regular exercise on the improvement of clinical 
outcomes in patients with coronary heart disease.1-3 In 2004, 
Taylor, et al.1 reported that CR was associated with a 20% re-
duction in all-cause mortality and a 25% reduction in cardiac 
death from a meta-analysis of randomized trials of ischemic 
heart disease. Also, in 2004, Hambrecht, et al.3 reported that a 
12-month program of regular physical exercise in patients 
with stable coronary artery disease showed superior event-
free survival and exercise capacity at lower costs to those who 
were treated with PCI. Also, recent data have demonstrated 
an inverse relationship between CR program participation 
and adverse cardiovascular events in an analysis of Medicare 
claims data, including 30161 patients with coronary artery 
disease who attended at least one CR session. After 4 years of 
follow up, patients who attended 36 sessions had a 14% lower 
risk of death and a 12% lower risk of myocardial infarction 
than those who attended 24 sessions; a 22% lower risk of 
death and a 23% lower risk of myocardial infarction than 
those who attended 12 sessions; and a 47% lower risk of death 
and a 31% lower risk of myocardial infarction than those who 
attended one session.10 Therefore, recent major guidelines 
from the American Heart Association and the American Col-
lege of Cardiology Foundation regarding the management 
and prevention of coronary heart disease provide a class 1 
level recommendation (i.e., procedure/treatment should be 
performed/administered) for referral to a CR program for pa-
tients with recent myocardial infarction or acute coronary 
syndrome, chronic stable angina, or heart failure or for pa-
tients following coronary artery bypass surgery or percutane-
ous coronary intervention.11,12 In line with previous findings, 
the CR+ group had fewer MACEs than the CR- group at 3 
years, although the difference was not statistically significant 
(9.9% vs. 18.3%, HR=0.54, p=0.122). However, different from 
previous studies, which were mainly performed in the bare-
metal stents era, the majority of the patients analyzed in our 
study was treated with second-generation DESs: of note, 94% 
of the patients received a second-generation DES. Although 
the advent of DES significantly lowered rates of in-stent reste-
nosis and the need of target-lesion revascularization, com-
pared to bare-metal stents, increased rates of stent thrombosis 
emerged as another concern, particularly for first-generation 
DESs. However, even in patients with STEMI, steady improve-
ments in outcomes have been realized with the evolution 
from bare-metal stent to first-generation and now second-
generation DES, with the most favorable safety and efficacy 
profile.13-15 Thus, these significant reductions in device-related 
MACEs with the use of second-generation DES might mitigate 
the clinical benefit of CR in the present study. Also, the small 
number of patients with a relatively short-term follow up in 
the present study may account for the lack of statistical signifi-
cance.
Despite the importance of participation in a CR program af-
ter myocardial infarction, participation rates have been re-
ported as only 22–30% according to recent studies.4-6 In the 
present study, among 254 STEMI patients who were dis-
charged after primary PCI, 76 patients (30%) participated in 
Fig. 3. Kaplan-Meier survival curves of MACEs according to preprocedural TIMI flow. CR, cardiac rehabilitation; PCI, percutaneous coronary interven-
tion; TIMI, thrombolysis in myocardial infarction; MACE, major adverse cardiovascular event.
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the CR program including exercise training. The major rea-
sons of the nonparticipants were refusal to enroll the pro-
gram. Therefore, it may be important to identify patients who 
would benefit from CR in patients with myocardial infarction. 
Although other clinical or procedural characteristics did not 
show a significant interaction in subgroup analysis, we found 
that there was a significant interaction in subgroup analysis 
according to CR group and preprocedural TIMI flow. Accord-
ing to a recent study, during primary PCI, low preprocedural 
TIMI flow was reversely associated with myocardial injury 
and was an independent predictor of myocardial damage as-
sessed by cardiac magnetic resonance.16 Also, patients under-
going primary PCI in whom TIMI-3 flow is present before an-
gioplasty present with greater clinical and angiographic 
evidence of myocardial salvage, are less likely to develop 
complications related to left ventricular failure, and have im-
proved early and late survival.17 In this sense, for patients with 
low preprocedural TIMI flow, CR could be more beneficial, 
compared to those with high preprocedural TIMI flow. 
This study has several limitations. First, this study was a ret-
rospective study of single-center data from a relatively small 
group of patients. Notwithstanding, we included patients with 
STEMI undergoing primary PCI in the current DES era, and 
second-generation DESs were used in 94%. Second, our study 
might be under-powered because of low event rates. Third, a 
longer follow up is needed. 
In conclusion, CR including exercise training was associat-
ed with fewer MACEs, particularly among patients with lower 
preprocedural TIMI flow, during primary PCI for STEMI in 
the current DES era.
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